Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

An insight to the diabetic ketoacidosis and lactic acidosis among the SARS-COV2 infected individuals

Breadcrumb

  • Home
  • An insight to the diabetic ketoacidosis and lactic acidosis among the SARS-COV2 infected individuals

Hussein Ali Hussein Al-Sa'idy 1, Ali Esmail Al-Snafi 2, * and BasimTurki Alyousif 3

1 Department of Environment and Pollution, Marshes research center, University of Thi-Qar, Iraq.
2 Department of Pharmacology, College of medicine, University of Thi-Qar, Iraq.
3 Department of Soil and Water, Marshes research center, University of Thi-Qar, Iraq.
 
Review Article
Magna Scientia Advanced Biology and Pharmacy, 2022, 06(01), 036–073
Article DOI: 10.30574/msabp.2022.6.1.0071
DOI url: https://doi.org/10.30574/msabp.2022.6.1.0071
Received on 28 April 2022; revised on 31 May 2022; accepted on 02 June 2022
 
A huge number of studies have demonstrated the significance correlation between diabetic ketoacidosis as well as other type of ketosis/hyperosmolar metabolic state deterioration conditions and the SARS-COV2 infection. It is investigated in various infected age group, geneders, and countries. It is reported to be correlated to the two types of diabetes (type I DM and type II DM) available as pre-existing co-morbidity, infection related new-onset developed diabetes of both types or even due to hyperinflammation related acute pancreatitis. In fact, although most of the studies have reported greater survival, however, small single center retrospective studies have reported the association of diabetic ketoacidosis with elevated mortality rate that approaches 50%. Mechanistically, the DKA caused metabolic state deterioration due to the glucose metabolism fluctuation is attributed to the bidirectional sophisticated SARS-COV2 infection and different reasons hyperglycemia disease-disease interaction. Nevertheless, exaggerated inflammatory/immune response may also worsen the glycemic state that brings about ketosis. Remarakably, DKA can be developed even in cases of approximately normoglycemic conditions of the SARS-COV2 infection which is fewly reported, yet, it is attributed to SGLT2 inhibitors therapy. The SARS-COV2 infection related DKA complication among diabetic individuals have been treated with the same therapeutic protocol of non-infectious conditions including insulin and IV replenishment therapy however, with significantly greater dosing regimen. It is worthy to note that the infused replenishment fluids should be carefully calculated along with monitoring the lung function besides careful monitoring the potassium and some other electrolytes level particularly while insulin is intravenously infused. Thus, in order to explore the significance of correlation of this metabolic complication with the virus infection poor prognosis as well as higher mortality rate this survey reports the development of DKA as well as the ketosis related metabolic abnormailities while the course of SARS-COV2 infection among individuals with pre-exisitng and new onset diabetes.
 
Diabetes; DKA; SARS-COV2 Infection; Acidosis; Prevalence; Mechanism
 
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2022-…

Preview Article PDF

Hussein Ali Hussein Al-Sa\'idy, Ali Esmail Al-Snafi and BasimTurki Alyousif. An insight to the diabetic ketoacidosis and lactic acidosis among the SARS-COV2 infected individuals. Magna Scientia Advanced Biology and Pharmacy, 2022, 6(1), 036-073. Article DOI: https://doi.org/10.30574/msabp.2022.6.1.0071

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution